Kabra Drugs Limited announced earnings results for the fourth quarter ended March 31, 2020. For the fourth quarter, the company announced total revenue was INR 226,000 compared to INR 0 a year ago. Net loss was INR 109,000 compared to INR 55,000 a year ago. Basic loss per share was INR 0.02 compared to INR 0.01 a year ago. For the full year, total revenue was INR 226,000 compared to INR 95,000 a year ago. Net loss was INR 596,000 compared to INR 1.647 million a year ago. Basic loss per share was INR 0.14 compared to INR 0.38 a year ago.